Phathom Pharmaceuticals Stock Market Value
| PHAT Stock | USD 8.97 0.12 1.32% |
| Symbol | Phathom |
Phathom Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phathom Pharmaceuticals. If investors know Phathom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phathom Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.74) | Revenue Per Share 0.44 | Return On Assets (0.58) | Return On Equity (34.89) |
The market value of Phathom Pharmaceuticals is measured differently than its book value, which is the value of Phathom that is recorded on the company's balance sheet. Investors also form their own opinion of Phathom Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Phathom Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phathom Pharmaceuticals' market value can be influenced by many factors that don't directly affect Phathom Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phathom Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Phathom Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phathom Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Phathom Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Phathom Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Phathom Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Phathom Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Phathom Pharmaceuticals or generate 0.0% return on investment in Phathom Pharmaceuticals over 30 days. Phathom Pharmaceuticals is related to or competes with Day One, Blueprint Medicines, Lyra Therapeutics, Cullinan Oncology, Acumen Pharmaceuticals, X4 Pharmaceuticals, and Inozyme Pharma. Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing tre... More
Phathom Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Phathom Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Phathom Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 40.1 | |||
| Value At Risk | (6.83) | |||
| Potential Upside | 8.25 |
Phathom Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Phathom Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Phathom Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Phathom Pharmaceuticals historical prices to predict the future Phathom Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (1.39) | |||
| Treynor Ratio | (2.30) |
Phathom Pharmaceuticals Backtested Returns
Phathom Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.12, which implies the firm had a -0.12% return per unit of risk over the last 3 months. Phathom Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Phathom Pharmaceuticals' Variance of 36.77, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,390) to confirm the risk estimate we provide. The company holds a Beta of 0.19, which implies not very significant fluctuations relative to the market. As returns on the market increase, Phathom Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Phathom Pharmaceuticals is expected to be smaller as well. At this point, Phathom Pharmaceuticals has a negative expected return of -0.73%. Please make sure to check Phathom Pharmaceuticals' jensen alpha, as well as the relationship between the skewness and day median price , to decide if Phathom Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.02 |
Very weak reverse predictability
Phathom Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Phathom Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Phathom Pharmaceuticals price movement. The serial correlation of -0.02 indicates that only 2.0% of current Phathom Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | -0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 1.35 |
Phathom Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Phathom Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Phathom Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Phathom Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Phathom Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Phathom Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Phathom Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Phathom Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Phathom Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Phathom Pharmaceuticals Lagged Returns
When evaluating Phathom Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Phathom Pharmaceuticals stock have on its future price. Phathom Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Phathom Pharmaceuticals autocorrelation shows the relationship between Phathom Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Phathom Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.